Connect Biopharma Holdings Ltd (CNTB)

Currency in USD
2.270
-0.110(-4.62%)
Closed·
After Hours
2.200-0.070(-3.08%)
·
CNTB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
1.7852.430
52 wk Range
0.5102.860
Key Statistics
Prev. Close
2.38
Open
2.43
Day's Range
1.785-2.43
52 wk Range
0.51-2.86
Volume
400.14K
Average Volume (3m)
136.09K
1-Year Change
71.97%
Book Value / Share
1.5
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNTB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.833
Upside
+201.03%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Connect Biopharma Holdings Ltd Company Profile

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company’s lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

Compare CNTB to Peers and Sector

Metrics to compare
CNTB
Peers
Sector
Relationship
P/E Ratio
−7.3x−4.4x−0.5x
PEG Ratio
−0.11−0.160.00
Price/Book
1.5x2.8x2.6x
Price / LTM Sales
4.8x10.0x3.2x
Upside (Analyst Target)
194.1%106.7%41.9%
Fair Value Upside
Unlock1.7%4.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.833
(+201.03% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.19 / -1.89
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNTB Income Statement

People Also Watch

1.27
KLTO
-5.93%
9.785
TRON
+13.65%
20.300
QBTS
+15.41%
6.070
AGEN
-0.82%
2.340
SQNS
-0.85%

FAQ

What Stock Exchange Does Connect Biopharma Holdings Trade On?

Connect Biopharma Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Connect Biopharma Holdings?

The stock symbol for Connect Biopharma Holdings is "CNTB."

What Is the Connect Biopharma Holdings Market Cap?

As of today, Connect Biopharma Holdings market cap is 126.12M.

What Is Connect Biopharma Holdings's Earnings Per Share (TTM)?

The Connect Biopharma Holdings EPS (TTM) is -0.31.

From a Technical Analysis Perspective, Is CNTB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Connect Biopharma Holdings Stock Split?

Connect Biopharma Holdings has split 0 times.

How Many Employees Does Connect Biopharma Holdings Have?

Connect Biopharma Holdings has 62 employees.

What is the current trading status of Connect Biopharma Holdings (CNTB)?

As of 24 Jul 2025, Connect Biopharma Holdings (CNTB) is trading at a price of 2.27, with a previous close of 2.38. The stock has fluctuated within a day range of 1.79 to 2.43, while its 52-week range spans from 0.51 to 2.86.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.